{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:07:33Z","timestamp":1770480453851,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.ghir.2006.04.003","type":"journal-article","created":{"date-parts":[[2006,6,3]],"date-time":"2006-06-03T07:18:41Z","timestamp":1149319121000},"page":"98-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"S","title":["Appropriate use of estrogen replacement therapy in adolescents and young adults with Turner syndrome and hypopituitarism in light of the Women\u2019s Health Initiative"],"prefix":"10.1016","volume":"16","author":[{"given":"Michelle P.","family":"Warren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2006.04.003_bib1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra030360","article-title":"Turner\u2019s syndrome","volume":"351","author":"Sybert","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2006.04.003_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Writing Group for the Women\u2019s Health Initiative Investigators","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ghir.2006.04.003_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1210\/jcem-73-3-555","article-title":"Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence","volume":"73","author":"Bonjour","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2006.04.003_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/eje.0.1380059","article-title":"Bone maturation in girls with Turner\u2019s syndrome","volume":"138","author":"Even","year":"1998","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2006.04.003_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2265.1999.00841.x","article-title":"Osteoporosis and fractures in Turner syndrome \u2013 importance of growth promoting and oestrogen therapy","volume":"51","author":"Landin-Wilhelmsen","year":"1999","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"2 Pt 3","key":"10.1016\/j.ghir.2006.04.003_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1542\/peds.102.S3.481","article-title":"Turner syndrome and osteoporosis: mechanisms and prognosis","volume":"102","author":"Rubin","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2006.04.003_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/jc.2003-030799","article-title":"Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry","volume":"89","author":"Hogler","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2006.04.003_bib8","first-page":"S320","article-title":"Effect of transdermal versus oral estrogen therapy on achieving near final adult height and near peak bone mass in growth hormone treated adolescents with Turner syndrome","volume":"19","author":"Yigit","year":"2004","journal-title":"J. Bone Min. Res."},{"key":"10.1016\/j.ghir.2006.04.003_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.0300-0664.2001.01464.x","article-title":"Fracture risk is increased in patients with GH deficiency or untreated prolactinomas \u2013 a case control study","volume":"56","author":"Vestergaard","year":"2002","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2006.04.003_bib10","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJM198012253032605","article-title":"Decreased bone density in hyperprolactinemic women","volume":"303","author":"Klibanski","year":"1980","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2006.04.003_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-104-6-777","article-title":"Osteoporosis in men with hyperprolactinemic hypogonadism","volume":"104","author":"Greenspan","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ghir.2006.04.003_bib12","first-page":"585","article-title":"Estrogen deficiency in adolescents and young adults: impact on bone mineral content and effects of estrogen replacement therapy","volume":"76","author":"Emans","year":"1990","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ghir.2006.04.003_bib13","first-page":"157","article-title":"Growth failure in early life: an important manifestation of Turner syndrome","volume":"57","author":"Davenport","year":"2002","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2006.04.003_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1530\/eje.0.1510657","article-title":"Epidemiological, endocrine and metabolic features in Turner syndrome","volume":"151","author":"Gravholt","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2006.04.003_bib15","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1210\/jc.2005-1081","article-title":"Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome","volume":"90","author":"Rosenfield","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2006.04.003_bib16","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0022-3476(86)80274-8","article-title":"Effect of low doses of estradiol on 6-month growth rates and predicted height in patients with Turner syndrome","volume":"109","author":"Ross","year":"1986","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ghir.2006.04.003_bib17","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM199406093302306","article-title":"Hypopituitarism","volume":"330","author":"Vance","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2006.04.003_bib18","first-page":"926","article-title":"Self-concept and behavior in adolescent girls with Turner syndrome: potential estrogen effects","volume":"81","author":"Ross","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2006.04.003_bib19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00004703-200112000-00003","article-title":"Psychosocial development in adolescents with Turner syndrome","volume":"22","author":"McCauley","year":"2001","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.ghir.2006.04.003_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00004703-199504000-00003","article-title":"Self-esteem and behavior in girls with Turner syndrome","volume":"16","author":"McCauley","year":"1995","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.ghir.2006.04.003_bib21","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1542\/peds.101.1.e11","article-title":"Cardiovascular malformations and complications in Turner syndrome","volume":"101","author":"Sybert","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2006.04.003_bib22","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2337\/diacare.21.7.1062","article-title":"Glucose metabolism, lipid metabolism and cardiovascular risk factors in adult Turner syndrome: the impact of sex hormone replacement","volume":"21","author":"Gravholt","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ghir.2006.04.003_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/jech.40.2.97","article-title":"Mortality ratios, life expectancy, and causes of death in patients with Turner\u2019s syndrome","volume":"40","author":"Price","year":"1986","journal-title":"J. Epidemiol. Commun. Health"},{"key":"10.1016\/j.ghir.2006.04.003_bib24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2265.2004.02196.x","article-title":"High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma","volume":"62","author":"Pereira","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2006.04.003_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.AOG.0000167394.38215.56","article-title":"Ovarian conservation at the time of hysterectomy for benign disease","volume":"106","author":"Parker","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ghir.2006.04.003_bib26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Women\u2019s Health Initiative Investigators, Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2006.04.003_bib27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ghir.2006.04.003_bib28","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/01.CIR.89.6.2545","article-title":"Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women","volume":"89","author":"Gilligan","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2006.04.003_bib29","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"The Women\u2019s Health Initiative Steering Committee, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ghir.2006.04.003_bib30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM198711053171901","article-title":"Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study","volume":"31","author":"Kiel","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2006.04.003_bib31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-128-9-199805010-00001","article-title":"Postmenopausal hormone use and risk for colorectal cancer and adenoma","volume":"128","author":"Grodstein","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ghir.2006.04.003_bib32","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","journal-title":"Lancet"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637406000487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637406000487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:43:03Z","timestamp":1761086583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637406000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":32,"alternative-id":["S1096637406000487"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2006.04.003","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appropriate use of estrogen replacement therapy in adolescents and young adults with Turner syndrome and hypopituitarism in light of the Women\u2019s Health Initiative","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2006.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}